Cure My Disease

Don't miss your cure!

 Log in / Sign up

Vacuum bandage may shield ECMO patients from wound infections

NCT ID NCT07709546

Prevention Sponsor: St. Antonius Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial tests whether a special vacuum dressing placed on the groin wound right after ECMO tube removal can prevent complications like infection, fluid buildup, or wound reopening. The dressing stays on for seven days without changes. The study includes adults on ECMO who are ready to come off the machine and have a groin cannula. If it works, this simple approach could improve recovery for these critically ill patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a vacuum dressing (closed-incision negative pressure wound therapy) applied to the groin wound immediately after ECMO tube removal and kept in place for seven days
What this could lead to
If effective, this simple dressing could become standard care to prevent wound infections and other complications in ECMO patients, speeding recovery and reducing hospital burden.
What could go wrong
This is a single-center trial with 144 participants, so results may not apply broadly. The dressing may cause skin irritation or need early removal, and it is unclear if it will meaningfully reduce complications over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient is aged 18 years or older * Is currently receiving ECMO therapy and is eligible for weaning from the device * The patient must have at least one cannula inserted at the groin site * (Proxy) informed consent Exclusion Criteria: * Duration ECMO run \< 24 hours * Expected death within 24 hours after decannulation * Extracorporeal carbon dioxide removal (ECCO2R) using low blood flow devices or pumpless devices (i.e., MINILUNG ®, PrismaLung+) * Wound closure is not possible after decannulation. * Presence of drain in the wound site * Participants who are not proficient in Dutch or English, or whose legal representative is not proficient, if applicable

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Extracorporeal membrane oxygenation (ECMO) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Extracorporeal membrane oxygenation (ECMO) Surgical site infection (SSI) Wound complications

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.